Venetoclax for chronic lymphocytic leukaemia patients who progress after more than one B ‐cell receptor pathway inhibitor

British Journal of Haematology, EarlyView.

Source: British Journal of Haematology - November 27, 2018 Category: Hematology Authors: William G. Wierda, John C. Byrd, Matthew S. Davids, Richard R. Furman, Bruce D. Cheson, Paul M. Barr, Herbert Eradat, Leonard Heffner, Lang Zhou, Maria Verdugo, Jalaja Potluri, Michael Choi Tags: Correspondence Source Type: research